#1 Clinical Trials Search in Europe

Bisacodyl

This article summarizes several clinical trials investigating the use of bisacodyl, a stimulant laxative, for treating constipation and improving bowel motility. Researchers have studied bisacodyl’s effects in various patient populations, including those with chronic constipation, multiple sclerosis, and post-surgical patients. The trials examine bisacodyl’s efficacy, safety, and impact on quality of life compared to placebos and other treatments.

Table of Contents

What is Bisacodyl?

Bisacodyl is a medication commonly used to treat constipation and to prepare the bowel for certain medical procedures. It’s known by various brand names, including Dulcolax[1]. Bisacodyl is classified as a stimulant laxative, which means it works by stimulating the intestines to move stool through the digestive system[2].

Uses of Bisacodyl

Bisacodyl is primarily used for the following purposes:

  • Treating constipation: It helps relieve occasional constipation by promoting bowel movements[1].
  • Preparing for medical procedures: It’s often used to clean out the intestines before colonoscopies or other intestinal procedures[3].
  • Managing postoperative care: Some studies have investigated its use in patients after surgery to help restore normal bowel function[1].
  • Treating anorectal dysfunction: Research has explored its potential in managing bowel problems associated with conditions like multiple sclerosis[2].

How Bisacodyl Works

Bisacodyl works in the large intestine (colon) to stimulate bowel movements. Here’s how it functions:

  1. It stimulates nerve endings in the intestines.
  2. This stimulation causes the muscles in the intestinal wall to contract.
  3. The contractions help move stool through the colon and out of the body.

Bisacodyl is designed with a special coating that prevents it from being digested in the stomach or small intestine. This means it only starts working when it reaches the large intestine[1].

How Bisacodyl is Administered

Bisacodyl can be taken in several forms:

  • Oral tablets: These are swallowed and typically take effect within 6-12 hours[1].
  • Rectal suppositories: These are inserted into the rectum and usually work within 15-60 minutes[2].

The dosage and timing can vary depending on the specific use and the patient’s condition. Always follow your healthcare provider’s instructions or the package directions carefully.

Effectiveness of Bisacodyl

Research has shown that bisacodyl can be effective for various purposes:

  • In postoperative care, it may help reduce the incidence of nausea, abdominal pain, and shorten hospital stays[1].
  • For bowel preparation before colonoscopies, it has been found to be effective when combined with other laxatives like polyethylene glycol (PEG)[3].
  • In patients with multiple sclerosis experiencing bowel problems, bisacodyl suppositories may help improve symptoms[2].

Potential Side Effects

While bisacodyl is generally considered safe when used as directed, it can cause some side effects. These may include:

  • Abdominal cramping
  • Nausea
  • Diarrhea
  • Electrolyte imbalances (if used excessively)

It’s important to use bisacodyl as directed and not to use it for extended periods without consulting a healthcare provider[1].

Ongoing Research

Researchers continue to study bisacodyl for various uses:

  • Its effectiveness in managing constipation and bloating when combined with other medications[4].
  • Its potential role in treating anorectal dysfunction in patients with multiple sclerosis[2].
  • Its use in bowel preparation protocols for colonoscopies, especially in patients with a history of colorectal surgery[5].

These ongoing studies aim to better understand how bisacodyl can be used most effectively and safely in different patient populations.

Study Focus Patient Population Bisacodyl Administration Key Outcomes Measured
Postoperative care OB/GYN surgery patients 5mg oral tablets Nausea, abdominal pain, hospital stay duration
Bowel motility after colorectal surgery Elective colorectal surgery patients 10mg oral capsules Time to bowel function recovery, hospital stay length
Anorectal dysfunction in multiple sclerosis Multiple sclerosis patients 10mg rectal suppository Bowel symptom improvement, quality of life
Constipation and bloating Patients with constipation and bloating Sugar-coated tablets Bloating relief, time to defecation
Bowel preparation for colonoscopy Patients undergoing colonoscopy 10mg with polyethylene glycol solution Bowel cleansing quality, patient tolerability

FAQ

  • What is bisacodyl and how does it work? Bisacodyl is a stimulant laxative medication. It works by activating nerves in the rectum to stimulate contractions, which leads to bowel movements. Bisacodyl is often used to treat constipation and prepare the bowel for medical procedures.
  • What conditions is bisacodyl being studied for in these clinical trials? The clinical trials are studying bisacodyl for various conditions including chronic constipation, postoperative ileus (slowed bowel function after surgery), constipation in multiple sclerosis patients, and as part of bowel preparation regimens before colonoscopy.
  • How is bisacodyl administered in these studies? Bisacodyl is administered in different ways across the studies, including oral tablets, rectal suppositories, and as part of combination regimens with other laxatives. Dosages and timing vary between trials.
  • What are some of the main outcomes being measured in these bisacodyl trials? Key outcomes being measured include time to first bowel movement, frequency of bowel movements, stool consistency, abdominal pain/discomfort, nausea/vomiting, quality of life measures, and overall bowel function scores. Safety and tolerability are also assessed.
  • Are there any notable side effects of bisacodyl mentioned in these studies? While specific side effects are not detailed in the trial summaries, common side effects of bisacodyl can include abdominal cramping, diarrhea, and nausea. The studies monitor for adverse events and safety outcomes related to bisacodyl use.

Ongoing Clinical Trials on Bisacodyl

  • Study on Preventing Constipation After Hip Fracture Surgery Using Bisacodyl and a Drug Combination for Post-Surgery Patients

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Effects of Botulinum Toxin Type A and a Drug Combination on Rectal Function in Patients with Fecal Incontinence

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study on the Effects of Naloxegol and Codeine on Opioid-Induced Constipation in Healthy Volunteers

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

Glossary

  • Postoperative ileus: A temporary impairment of bowel motility that can occur after abdominal surgery, leading to symptoms like nausea, vomiting, and delayed bowel movements.
  • Bowel preparation: The process of cleansing the bowel before a medical procedure like colonoscopy, often involving laxatives to empty the colon.
  • Motility: The movement of food and waste through the digestive system by muscle contractions in the intestines.
  • Placebo: An inactive substance or treatment used in clinical trials to compare against the effects of the drug being studied.
  • Randomized clinical trial: A type of study where participants are randomly assigned to different treatment groups to compare outcomes.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Quality of life: A measure of a person's overall well-being and ability to function in daily life, often assessed in clinical trials.
  • Adverse event: Any unfavorable or unintended sign, symptom, or disease that occurs during a clinical trial, whether or not it is caused by the treatment being studied.

References

  1. https://clinicaltrials.gov/study/NCT01011426
  2. https://clinicaltrials.gov/study/NCT02609607
  3. https://clinicaltrials.gov/study/NCT02980562
  4. https://clinicaltrials.gov/study/NCT02211976
  5. https://clinicaltrials.gov/study/NCT01887158